Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome - Concepedia

Concepedia

Publication | Open Access

Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome

DOI Full Paper Access

275

Citations

26

References

2022

Year

Hirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki, Ko Yamamoto, Yuki Obayashi, Manabu Ogita, Satoru Suwa, Tsuyoshi Isawa, Takenori Domei, Kyohei Yamaji,

JAMA Cardiology

Abstract

ClinicalTrials.gov Identifiers: NCT02619760 and NCT03462498.

References

	Year	Citations
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes Lars Wallentin, Richard C. Becker, Andrzej Budaj, New England Journal of Medicine	2009	7K
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes Stephen D. Wiviott, Eugene Braunwald, Carolyn H. McCabe, New England Journal of Medicine	2007	6.7K
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation New England Journal of Medicine	2001	6.4K
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Jean‐Philippe Collet, Hölger Thiele, Emanuele Barbato, European Heart Journal Heart FailureCoronary Artery DiseaseAcute Myocardial InfarctionThrombosisPersistent St-segment Elevation	2020	4.9K
Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease Patrick W. Serruys, Marie‐Claude Morice, A. Pieter Kappetein, New England Journal of Medicine	2009	4.3K
Third Universal Definition of Myocardial Infarction Kristian Thygesen, Joseph S. Alpert, Allan S. Jaffe, Circulation	2012	2.9K
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS Marco Valgimigli, Héctor Bueno, Robert A. Byrne, European Heart Journal	2017	2.9K
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Shamir R. Mehta, Salim Yusuf, Ron J.G. Peters, The Lancet Percutaneous Coronary InterventionThrombosisPci-cure StudyCardiovascular DiseaseCoronary Artery Disease	2001	2.8K
Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase Anupama Rao, Craig M. Pratt, Andrew Berke, Journal of the American College of Cardiology ThrombosisPlasma FibrinogenCardiovascular DiseaseFibrinolytic SystemHematology	1988	986
Ticagrelor with or without Aspirin in High-Risk Patients after PCI Roxana Mehran, Usman Baber, Samin K. Sharma, New England Journal of Medicine	2019	957

Page 1